Excellence research network on microbiota and infectious diseases.
Cynbiome® is a preclinical network dedicated to the microbiome and infectious deseases research field which capitalize on the richness and complementarity of players specializing in various fields such as high-throughput sequencing, biomanufacturing, imaging, microfluidics, specific analyses, biomarkers, preclinical and clinical activities.
Cynbiome® provide a preclinical offer with a core focus on the microbiome field and infectious diseases and pursue R&D activities. The Cynbiome® preclinical network was launched by Cynbiose and is financed by the French government and the Auvergne-Rhône-Alpes region and is supported by Bpifrance.
VirNext is co-founder of the Cynbiome® preclinical network launched by our strategic partner cynbiose. We bring our technologies, virus library, preclinical infectious models and BSL-2/BSL-3 facilities to the @Cynbiome® network. Our objectives are to offer a large preclinical offer with a core focus on the microbiome field and infectious diseases, in order to accelerate and de-risk the development of candidates to meet the major challenges of human health.